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RESEARCH
Common elective orthopaedic procedures and their clinical 
 effectiveness: umbrella review of level 1 evidence




To determine the clinical effectiveness of common 
elective orthopaedic procedures compared with no 
treatment, placebo, or non-operative care and assess 
the impact on clinical guidelines.
DESIGN
Umbrella review of meta-analyses of randomised 
controlled trials or other study designs in the absence 
of meta-analyses of randomised controlled trials.
DATA SOURCES
Ten of the most common elective orthopaedic 
procedures—arthroscopic anterior cruciate ligament 
reconstruction, arthroscopic meniscal repair of the 
knee, arthroscopic partial meniscectomy of the 
knee, arthroscopic rotator cuff repair, arthroscopic 
subacromial decompression, carpal tunnel 
decompression, lumbar spine decompression, 
lumbar spine fusion, total hip replacement, and total 
knee replacement—were studied. Medline, Embase, 
Cochrane Library, and bibliographies were searched 
until September 2020.
ELIGIBILITY CRITERIA FOR SELECTING STUDIES
Meta-analyses of randomised controlled trials (or in 
the absence of meta-analysis other study designs) 
that compared the clinical effectiveness of any of 
the 10 orthopaedic procedures with no treatment, 
placebo, or non-operative care.
DATA EXTRACTION AND SYNTHESIS
Summary data were extracted by two independent 
investigators, and a consensus was reached with 
the involvement of a third. The methodological 
quality of each meta-analysis was assessed using 
the Assessment of Multiple Systematic Reviews 
instrument. The Jadad decision algorithm was used 
to ascertain which meta-analysis represented the 
best evidence. The National Institute for Health 
and Care Excellence Evidence search was used to 
check whether recommendations for each procedure 
reflected the body of evidence.
MAIN OUTCOME MEASURES
Quality and quantity of evidence behind common 
elective orthopaedic interventions and comparisons 
with the strength of recommendations in relevant 
national clinical guidelines.
RESULTS
Randomised controlled trial evidence supports the 
superiority of carpal tunnel decompression and 
total knee replacement over non-operative care. No 
randomised controlled trials specifically compared 
total hip replacement or meniscal repair with non-
operative care. Trial evidence for the other six 
procedures showed no benefit over non-operative 
care.
CONCLUSIONS
Although they may be effective overall or in certain 
subgroups, no strong, high quality evidence base 
shows that many commonly performed elective 
orthopaedic procedures are more effective than 
non-operative alternatives. Despite the lack of 
strong evidence, some of these procedures are still 





About 200 musculoskeletal conditions have a 
substantial effect on the quality of life of millions of 
people in the UK and are associated with increased 
healthcare costs.1 According to the World Health 
Organization, the most common and disabling 
musculoskeletal conditions are osteoarthritis, back 
and neck pain, fractures associated with fragility of the 
bone, injuries, and systemic inflammatory conditions 
such as rheumatoid arthritis. Musculoskeletal 
conditions are typically characterised by persistent 
pain and restricted mobility. According to the 2017 
Global Burden of Disease study, musculoskeletal 
conditions were the biggest contributor to global 
disability.2 Although many musculoskeletal 
conditions can be managed in primary care through 
a combination of core interventions such as exercise, 
weight management, physical therapies, psychological 
therapies, and drug treatment, some patients who do 
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WHAT IS ALREADY KNOWN ON THIS TOPIC
The burden of musculoskeletal conditions on health services is large, with more 
than one million patients undergoing surgical interventions according to Hospital 
Episode Statistics
The National Institute for Health and Care Excellence, NHS, and British 
Orthopaedic Association produce national clinical guidelines recommending 
common elective orthopaedic interventions
These recommendations often lack strong supporting evidence, particularly in 
the form of randomised controlled trials
WHAT THIS STUDY ADDS
Most common elective orthopaedic interventions are not backed up by readily 
available high quality evidence, mostly owing to a lack of definitive randomised 
controlled trials
Of the procedures studied, carpal tunnel decompression and total knee 
replacement showed superiority over non-operative care
An urgent need exists to prioritise research into common elective orthopaedic 
interventions compared with no treatment, placebo, and non-operative treatment
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not respond to conservative measures need specialist 
care, surgical care, or both.3 In the UK, musculoskeletal 
conditions account for more than 25% of all surgical 
interventions in the National Health Service (NHS).
Total joint replacement is one of the most common 
elective orthopaedic procedures performed worldwide 
for end stage osteoarthritis, the most common 
musculoskeletal condition.4 Although total joint 
replacement is considered to be a clinically effective 
intervention for the management of osteoarthritis, 
it also accounts for enormous expenditures in the 
health system. The term “clinical effectiveness” is 
about ensuring that healthcare practice is based on the 
best available data and evidence of effectiveness. The 
National Institute for Health and Care Excellence (NICE) 
defines the “clinical effectiveness of a treatment” as 
how beneficial the treatment is under usual or everyday 
conditions, compared with doing nothing or opting 
for another type of care.5 Randomised controlled 
trials are considered the best method to evaluate the 
clinical effectiveness of an intervention. They deliver 
the highest level of evidence owing to their potential 
to minimise bias. Concerns have been expressed that 
many orthopaedic surgical interventions, as well as 
prostheses used in these interventions, do not have 
readily available or high quality evidence on their 
clinical effectiveness to support their use.6 7 A recent 
review found that 24% of all hip replacement implants 
available to surgeons in the UK did not have evidence 
for their clinical effectiveness.8 Although clinical 
guidelines, defined as “systematically developed 
statements to assist practitioner and patient decisions 
about appropriate health care for specific clinical 
circumstances,”9 aim to be informed by the best 
available evidence, they have often been criticised for 
their lack of methodological rigour and applicability.10 11 
A critical appraisal of existing treatment guidelines 
for the management of hip and knee osteoarthritis by 
the Osteoarthritis Research Society International’s 
Treatment Guidelines Committee observed that the 
overall quality of existing guidelines was suboptimal 
and consensus recommendations were not always 
supported by the best available evidence.
Whether common orthopaedic procedures 
for managing musculoskeletal conditions are 
accompanied by high quality evidence bases is unclear. 
In this context, using an umbrella review of systematic 
reviews/meta-analyses of randomised controlled trials 
or other study designs in the absence of meta-analyses 
of randomised controlled trials, we aimed to evaluate 
the clinical effectiveness of the 10 most common 
elective orthopaedic procedures, assess whether the 
evidence base on these 10 orthopaedic procedures has 




We did an umbrella review—a systematic collection 
and critical evaluation of multiple systematic reviews/
meta-analyses on a specific research topic.12 This was 
conducted according to PRISMA (Preferred Reporting 
Items for Systematic Reviews and Meta- Analyses) and 
MOOSE (Meta-analyses of Observational Studies in 
Epidemiology) guidelines13 14 (appendices 1 and 2) 
and was based on a predefined protocol registered in 
the PROSPERO international prospective register of 
systematic reviews (CRD42018115917).
Selection of 10 common elective orthopaedic 
procedures
To identify the 10 most elective common orthopaedic 
procedures and their indications (table 1), we 
combined a literature search for relevant articles on 
the topic, an assessment of Hospital Episode Statistics 
procedure frequency counts, and discussions with 
prominent and experienced orthopaedic surgeons. We 
used these three approaches in parallel and compared 
their results. As the results were generally concordant, 
no further selection or arbitration process was needed.
Data sources, search strategy, and study selection
We searched Medline, Embase, and the Cochrane 
Library from inception to September 2020 for studies 
that compared the clinical effectiveness of each 
of the selected orthopaedic interventions with no 
treatment, placebo, or non-operative care. We did 
separate searches for each orthopaedic procedure. The 
computer based searches combined free and MeSH 
search terms and keywords related to the orthopaedic 
procedure (for example, “total knee replacement”, 
“total hip replacement”, “carpal tunnel surgery”) and 
population (for example, “osteoarthritis”, “carpal 
tunnel syndrome”, “subacromial impingement 
syndrome”). We applied filters for systematic reviews/
meta-analyses. We restricted the search to articles 
written in the English language because our study 
design was an umbrella review of systematic reviews/
meta-analyses and we took into consideration the 
extent of the literature included by each contributing 
review during our selection of the best currently 
available evidence for a procedure. The detailed 
strategy for each orthopaedic procedure is reported 
in appendix 3. We screened all titles and abstracts of 
retrieved citations to assess suitability for inclusion. 
Two authors (SKK and RLD) independently evaluated 
the full text of articles potentially meeting eligibility 
criteria for study selection. When necessary, 
discrepancies were discussed and consensus reached 
with the involvement of a third author (MRW). To 
account for studies missed in the original search, we 
manually scanned reference lists of eligible articles.
Eligibility criteria
Studies were eligible if they were systematic reviews/
meta-analyses including randomised controlled trials 
that compared the clinical effectiveness of any of 
the orthopaedic procedures mentioned above with 
no treatment, placebo, or non-operative care. In the 
absence of meta-analyses of randomised controlled 
trials, we sought individual randomised controlled 
trials followed by systematic reviews/meta-analyses of 
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observational cohort studies, in that order, according 
to the hierarchy of evidence (appendix 4).15 We 
excluded network meta-analyses (when pairwise meta-
analyses were available), narrative reviews, systematic 
reviews that did not pool data or do a meta-analysis, 
and meeting abstracts. For multiple Cochrane reviews 
evaluating the same topic, we selected the most 
recently updated one.
Data extraction, quality, and risk of bias assessment
One author (SKK) initially extracted data by using a 
standardised data collection form. A second author 
(RLD) independently checked the extracted data against 
the original articles. In the event of discrepancies 
between authors, a third author (MRW) was consulted. 
We extracted information on the first author’s name, year 
and journal of publication, databases searched, number 
of component randomised controlled trials, outcomes 
and findings, type of effect model used in the meta-
analysis (fixed or random), between study heterogeneity 
estimates (I2 values), any presented measure of 
publication bias, Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) 
rating, sources of funding, and conflicts of interest. We 
explored whether the studies evaluated possible sources 
of heterogeneity across studies by using methods such 
as subgroup analyses and whether the authors formally 
conducted a sensitivity analysis.
We assessed the methodological quality of each 
included meta-analysis by using the Assessment of 
Multiple Systematic Reviews (AMSTAR) instrument,16 
an 11 item tool that is widely recognised for assessing 
the methodological quality of systematic reviews/
meta-analyses and has good reliability and external 
validity.17 18 The tool includes ratings for quality in the 
search, analysis, and transparency of a meta-analysis. 
The maximum score achievable by a review is 11. 
Regarding the rating item for methodological quality in 
the analysis, we downgraded any study that had used a 
fixed effects model rather than a random effects model 
for producing a summary estimate. We considered 
the random effects model to be the most appropriate 
pooling approach given the heterogeneity in study 
designs and populations in orthopaedic research.
Selecting best body of evidence for each procedure
We used the Jadad decision algorithm (fig 1) to provide 
recommendations for the use of each orthopaedic 
procedure.19 Given the conflicts among systematic 
reviews/meta-analyses that produce difficulties for 
decision makers in making recommendations on a 
particular intervention, the Jadad decision algorithm 
was developed to help decision makers to select among 
discordant reviews.19 This tool determines the source 
of discordance between systematic reviews, including 
differences in clinical question, inclusion and 
exclusion criteria, data extraction, quality assessment, 
data pooling, and statistical analysis (fig 1). It has 
been and is now widely used to develop treatment 
recommendations from among meta-analyses with 
discordant results.20 21 Two authors independently 
applied the algorithm and arrived at a consensus as to 
which of the meta-analyses provided the best available 
evidence. We did not use the Jadad decision algorithm 
if all meta-analyses for an orthopaedic procedure 
considered the same study question and reported 
similar results. Furthermore, given that randomised 
controlled trials included in each meta-analysis varied 
in their methodological quality, we needed to put the 
overall findings in the context of the best available 
evidence (as a type of sensitivity analysis). Hence, we 
selected and summarised the results of randomised 
controlled trials with a low risk of bias from each meta-
analysis, representing the best body of evidence for 
each procedure. Finally, following the collection of the 
evidence, we compared findings for each procedure 
with national guidelines (NICE evidence search) to 
check whether recommendations for each procedure 
reflected the body of available evidence.
Patient and public involvement
In the Musculoskeletal Research Unit of the University 
of Bristol and North Bristol NHS Trust, we have a 
dedicated patient and public involvement group, the 
Patient Experience Partnership in Research (PEP-R).22 
This comprises patients, all of whom have undergone 
core treatments for various musculoskeletal conditions. 
It is a facilitated group that works in partnership 
with researchers to provide patient and public input 
into research and helps to identify avenues for the 
dissemination of research findings. Members of the 
research team have regularly met with this group to 
ensure that every research project in the unit remains 
relevant to patients. Our regular meetings with the 
group inspired this review.
Results
The study selection process from retrieval of search 
results to inclusion in the umbrella review is illustrated 
in the PRISMA flow diagram (fig 2), according to each 
orthopaedic procedure. A full reference list of the 
included studies is provided in appendix 5.
Arthroscopic anterior cruciate ligament 
reconstruction for anterior cruciate ligament 
deficiency
Of 120 citations retrieved for anterior cruciate 
ligament reconstruction, three articles were eligible 
for the review (fig 2; appendix 5). Publication dates 
ranged from 2014 to 2020, and AMSTAR scores 
Table 1 | Common elective orthopaedic procedures and indications
Procedure Main indication
Arthroscopic anterior cruciate ligament reconstruction Anterior cruciate ligament rupture
Arthroscopic meniscal repair of the knee Traumatic meniscal tears
Arthroscopic partial meniscectomy of the knee Degenerative meniscal tears
Arthroscopic rotator cuff repair Acute rotator cuff tears
Arthroscopic subacromial decompression Subacromial impingement syndrome
Carpal tunnel decompression Carpal tunnel syndrome
Lumbar spine decompression Spinal canal stenosis
Lumbar spine fusion Degenerative disc disease
Total hip replacement End stage osteoarthritis
Total knee replacement End stage osteoarthritis
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ranged from 9 to 11 (appendices 6 and 7). Two 
reviews included a mix of comparative observational 
cohort studies and one randomised controlled trial 
each, which compared surgical treatment (anterior 
cruciate ligament reconstruction) with non-surgical 
treatment. The third was a Cochrane review, which 
evaluated one randomised controlled trial. All three 
reviews in their pooled analyses showed no difference 
B Select question closest to solving problem C Same trials?
D Same quality?
E
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Fig 2 | PRISMA flow diagram. ACL=anterior cruciate ligament










J: first published as 10.1136/bm





the bmj | BMJ 2021;374:n1511 | doi: 10.1136/bmj.n1511 5
in patient reported outcome measures (fig 3), and 
the GRADE quality of the evidence was low. A total 
of two randomised controlled trials were included in 
the three reviews, and each reported no differences 
in patient reported outcome measures between 
surgical treatment and non-surgical treatment. The 
randomised controlled trial by Frobell and colleagues, 
which compared structured rehabilitation plus 
early anterior cruciate ligament reconstruction with 
structured rehabilitation plus optional later anterior 
cruciate ligament reconstruction in 121 adults with 
acute anterior cruciate ligament injuries, represented 
the best body of evidence for anterior cruciate ligament 
reconstruction.23 24 Patient reported or radiographic 
outcomes and adverse events did not differ between the 
two interventions after two and five years (appendices 
8 and 9).
Arthroscopic meniscal repair of the knee for 
traumatic tears
Of 26 retrieved articles, no reviews of randomised 
controlled trials comparing arthroscopic meniscal 
repair with no treatment, placebo, or non-operative 
care were identified (fig 2; appendix 5). However, 
we identified a review of mostly observational 
studies (including one randomised controlled trial) 
that compared meniscal repair (open suture and 
arthroscopic inside-out procedures) with meniscectomy 
(arthroscopic partial or total meniscectomy) 
(appendices 8 and 9). In this review, meniscal repairs 
were reported to have better long term patient reported 
outcome measures, better activity levels, and lower 
failure rates than meniscectomy (fig 3). In the single 
randomised controlled trial that compared a variety of 
surgical procedures (arthroscopic repair, arthroscopic 
minimal resection and repair, or arthroscopic partial 
meniscectomy) with non-surgical treatment,25 clinical 
findings based on International Knee Documentation 
Committee protocols suggested that non-surgical 
treatment was unsatisfactory.
Arthroscopic partial meniscectomy of knee for 
degenerative tears
Of 82 retrieved articles on arthroscopic partial 
meniscectomy, six were eligible for evaluation (fig 
2; appendix 5). Characteristics and findings of each 
meta-analysis are provided in appendix 6. Publication 
dates ranged from 2014 to 2020. AMSTAR scores 
ranged from 8 to 11 (appendix 7). In all six reviews 
of randomised controlled trials, arthroscopic partial 
meniscectomy did not show clinically important benefit 
over conservative treatment for knee function and 
pain. In the most recent review, which was based on 
10 randomised controlled trials, arthroscopic partial 
meniscectomy did not provide a clinically meaningful 














































































































































Participant rated global assessment of treatment success
Gra rupture/subsequent ACL reconstruction
Subsequent meniscectomy
Failure rate
Improvement in clinical symptoms
Improvement in grip strength
Improvement of neurophysiological parameters
Reoperation
Complications
Fig 3 | Overall findings of umbrella review by outcome measures and orthopaedic procedures. ACL=anterior cruciate ligament; IKDC=International 
Knee Documentation Committee; KOOS=Knee Injury and Osteoarthritis Outcome Score
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(fig 3). However, small benefits of arthroscopic partial 
meniscectomy were reported for patients without 
osteoarthritis. The authors indicated that surgical 
treatment should not be considered the first line 
intervention for patients with knee pain and meniscal 
tear. The GRADE quality of the evidence ranged from 
low to high. Two randomised controlled trials were 
identified to represent the best body of evidence 
for arthroscopic partial meniscectomy.26 27 In a 
comparison of arthroscopic partial meniscectomy plus 
postoperative physical therapy with a standardised 
physical therapy regimen in patients with symptoms, 
a meniscal tear, and evidence of mild to moderate 
osteoarthritis on imaging, no significant differences 
were seen between the study groups in functional 
improvement and frequency of adverse events.26 In 
140 middle aged patients with degenerative meniscal 
tears, arthroscopic partial meniscectomy provided 
no clinically relevant difference in Knee Injury and 
Osteoarthritis Outcome Score compared with a 12 
week supervised exercise programme, and no serious 
adverse events occurred in either group (appendices 8 
and 9).27
Arthroscopic rotator cuff repair for acute rotator cuff 
tears
Of 117 retrieved articles on rotator cuff repair, 
three meta-analyses were eligible for the review (fig 
2; appendix 5). Their general characteristics and 
outcomes are provided in appendix 6. Their publication 
dates ranged from 2015 to 2019. AMSTAR scores 
ranged from 7 to 11 (appendix 7). One study compared 
arthroscopic versus mini-open rotator cuff repair and 
reported no differences in surgery time, functional 
outcome score, visual analogue scale pain score, and 
range of motion between the two techniques. In a 
Cochrane review that mainly compared arthroscopic 
rotator cuff repair with or without subacromial 
decompression versus non-operative treatment 
(exercises with or without glucocorticoid injection) as 
well as other comparisons, arthroscopic rotator cuff 
repair provided little or no clinically important benefits 
for pain, function, quality of life, or participant rated 
global assessment of treatment success compared with 
non-operative treatment (fig 3). In the third review, 
which compared surgical repair versus conservative 
treatment or subacromial decompression alone for 
degenerative rotator cuff tears, surgical repair resulted 
in significantly improved outcomes (Constant-Murley 
score) compared with other strategies. Surgical repair 
comprised a variety of techniques including mini-
open, open, or arthroscopic rotator cuff repair, and 
no subgroup analysis was done for arthroscopic 
versus open repair. None of the trials included in the 
reviews compared arthroscopic rotator cuff repair with 
no treatment or placebo. The GRADE quality of the 
evidence ranged from very low to moderate. Given that 
the three reviews did not investigate the same research 
question (compared different strategies), we selected 
the review with the question closest to ours on the 
basis of the Jadad decision algorithm (fig 1). The best 
available was the Cochrane review,28 which showed no 
clinically important benefits of arthroscopic rotator cuff 
repair over non-operative care (fig 3). In two selected 
randomised controlled trials that represented the best 
body of evidence and compared rotator cuff repair with 
physiotherapy, no clinically important differences were 
observed between the two interventions at short term 
and long term follow-up (appendices 8 and 9).29-32
Arthroscopic subacromial decompression for 
subacromial impingement syndrome
We retrieved 81 articles on arthroscopic subacromial 
decompression, and three fulfilled the eligibility 
criteria (fig 2; appendix 5). A general description of 
the characteristics of each meta-analysis is provided 
in appendix 6. All studies were published in 2019 
and 2020. AMSTAR scores ranged from 9 to 11 
(appendix 7). All three reviews compared subacromial 
decompression surgery for subacromial impingement 
syndrome/subacromial pain syndrome/rotator cuff 
disease with any other treatment (placebo, exercise 
therapy, physiotherapy, or no intervention). All three 
reviews indicated that subacromial decompression 
did not provide clinically important improvement in 
pain, function, or quality of life compared with other 
treatments (fig 3). Two meta-analyses compared open 
versus arthroscopic subacromial decompression 
and reported similar clinical outcomes, although 
arthroscopic subacromial decompression was 
associated with a quicker return to work and shorter 
length of stay in hospital.33 34 We identified two 
randomised controlled trials to represent the best body of 
evidence for arthroscopic subacromial decompression. 
They both reported no clinically important differences 
in patient reported outcomes and adverse events 
between arthroscopic subacromial decompression and 
placebo surgery (appendices 8 and 9).35 36
Carpal tunnel decompression for carpal tunnel 
syndrome
Of 50 retrieved citations on carpal tunnel 
decompression, nine meta-analyses of randomised 
controlled trials were eligible for the review (fig 2; 
appendix 5). Publication dates ranged from 2008 
to 2019, and AMSTAR scores ranged from 7 to 11 
(appendices 6 and 7). Eight of the reviews compared 
endoscopic or limited incision with open or standard 
incision carpal tunnel decompression for the treatment 
of carpal tunnel syndrome. Only one meta-analysis 
compared surgical versus non-surgical treatment.
In the single meta-analysis that synthesised four 
randomised controlled trials comparing surgical 
versus non-surgical treatment (splinting or local 
corticosteroid injections), surgical treatment was 
shown to relieve symptoms significantly better than 
non-surgical treatment; however, surgical treatment 
was associated with more complications (fig 3). No 
randomised controlled trials compared carpal tunnel 
decompression with placebo or no treatment.
For the comparison between endoscopic versus 
open carpal tunnel decompression, the results were 
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discordant across the eight reviews. However, general 
findings suggested that endoscopic and open release 
are about as effective as each other in relieving 
symptoms and improving functional status, although 
endoscopic release may have functional benefits over 
the open release with regards to return to work and 
improved grip strength. Some evidence suggested that 
endoscopic release increased the risk of nerve injury 
compared with open release. The GRADE quality of the 
evidence ranged from very low to low. On the basis of 
the fact that most reviews that investigated the same 
research question did not include the same trials and 
selection criteria were similar, the Jadad decision 
algorithm indicated that the best available evidence 
should be chosen according to search strategies and 
application of selection criteria (fig 1). Hence, we 
selected the Cochrane review.37 The findings, which 
were based on very low to low quality GRADE evidence, 
indicated that open and endoscopic releases for carpal 
tunnel syndrome are about as effective as each other in 
relieving symptoms and improving functional status, 
although endoscopic release may have a functionally 
significant benefit over open release for improvement 
in grip strength. In all three selected randomised 
controlled trials that represented the best body of 
evidence and compared carpal tunnel surgery (mostly 
open release) with non-surgical treatment (wrist 
splinting, steroid injection, or hand therapy), surgery 
was more effective in most outcome measures (overall 
symptom improvement, paraesthesia, function, 
median nerve distal motor latencies, and sensory 
nerve conduction velocity) (appendices 8 and 9).38-40
Lumbar spine decompression for spinal canal 
stenosis
Of 137 retrieved citations for lumbar spine 
decompression, 12 meta-analyses of randomised 
controlled trials were eligible for the review (fig 
2; appendix 5). Publication dates ranged from 
2011 to 2020, and AMSTAR scores ranged from 6 
to 11 (appendices 6 and 7). Three meta-analyses 
compared surgical procedures (decompression, spinal 
fusion, interspinous process device implantation, 
and laminectomy) versus non-surgical treatment 
(orthosis, rehabilitation, physical therapy, exercise, 
heat and cold therapies, transcutaneous electrical 
nerve stimulation, ultrasonography, analgesics, non-
steroidal anti-inflammatory drugs, epidural steroids, 
and cognitive-behavioural treatments), and nine 
meta-analyses compared two or more surgical or 
decompression procedures (decompression, spinal 
fusion, decompression plus fusion, interspinous 
process device implantation, discectomy, laminectomy, 
and laminotomy). The three meta-analyses comparing 
surgical treatment (mostly decompression procedures) 
with non-surgical treatment showed similar effects for 
operative and non-operative interventions (fig 3). The 
GRADE quality of the evidence was low.
For the comparisons among different surgical 
procedures, the results were generally consistent: 
no differences were seen in outcomes such as pain 
intensity, physical function or disability status, quality 
of life, recovery, perioperative blood loss, operation 
time, length of stay in hospital, and reoperation rates 
when the techniques were compared with each other. 
However, interspinous process device implantation 
seemed to be associated with higher reoperation rates 
than spinal decompression. No randomised controlled 
trials have compared lumbar spinal decompression 
with no treatment or placebo. In the single selected 
randomised controlled trial that represented the 
best body of evidence and compared segmental 
decompression with conservative treatment (non-
steroidal anti-inflammatory drugs and physiotherapy), 
both treatment groups showed improvement during 
follow-up with no difference in walking ability 
(appendices 8 and 9).41
Lumbar spine fusion for degenerative disc disease
Of 139 retrieved citations on lumbar spine fusion, 13 
meta-analyses of randomised controlled trials were 
eligible for the review (fig 2; appendix 5). Publication 
dates ranged from 2010 to 2020, and AMSTAR scores 
ranged from 6 to 11 (appendices 6 and 7). Nine meta-
analyses compared lumbar spine fusion with total disc 
replacement, two compared lumbar spine fusion with 
non-operative management (physical therapy, patient 
education, exercise, pain relief by acupuncture and 
injections), and two compared minimally invasive 
with open transforaminal lumbar interbody fusion 
for single level degenerative disease. The two meta-
analyses comparing lumbar spine fusion with non-
operative management both reported no differences in 
Oswestry Disability Index scores; however, one review 
reported that lumbar spine fusion was associated with 
surgical complications (fig 3).
For the comparison between lumbar spine fusion 
and total disc replacement, the results were variable 
in the earlier reviews. With the publication of newer 
randomised controlled trials, recent reviews showed 
that total disc replacement significantly improved 
pain and patient satisfaction, reduced reoperation 
rate and operation time, shortened duration of 
hospital admission, and decreased post-surgical 
complications compared with lumbar spine fusion in 
both the short term and the long term. The findings 
of the two reviews comparing minimally invasive 
versus open transforaminal lumbar interbody fusion 
for single level degenerative disease were discordant 
except for less blood loss and longer fluoroscopy time 
with the minimally invasive approach. On the basis 
of similarities in the research question and selection 
criteria, and differences in included trials, the Jadad 
decision algorithm indicated that the best available 
evidence should be chosen according to search 
strategies and application of selection criteria (fig 1). 
The best available evidence showed that the minimally 
invasive procedure was associated with less blood loss, 
shorter hospital stay, and slightly less disability.42 No 
randomised controlled trials have compared lumbar 
spine fusion with no treatment, placebo, or sham 
surgery. We selected two randomised controlled trials 
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to represent the best body of evidence for lumbar spine 
fusion. Both trials compared lumbar spine fusion 
with cognitive intervention and exercises and showed 
no differences in success rates and return to work 
(appendices 8 and 9).43 44
Total hip replacement for end stage osteoarthritis
Of 168 retrieved articles, no reviews of randomised 
controlled trials comparing total hip replacement 
with no treatment, placebo, or sham surgery for the 
treatment of end stage osteoarthritis were identified 
(fig 2; appendix 5). We found no individual randomised 
controlled trials comparing total hip replacement 
versus non-surgical treatment. Three systematic 
reviews evaluated the clinical effectiveness of total 
hip replacement versus resurfacing arthroplasty for 
the treatment of end stage osteoarthritis of the hip 
(appendix 6). Their AMSTAR scores ranged from 4 to 
6 (appendix 7). The evidence on functional outcomes, 
failure rate, and mortality was inconclusive; the risks 
of revision and component loosening were higher but 
the risk of implant dislocation was lower in patients 
receiving resurfacing arthroplasty compared with total 
hip replacement. The GRADE quality of the evidence 
ranged from very low to low.45 We also identified three 
individual randomised controlled trials that compared 
the effectiveness of resurfacing arthroplasty with 
that of total hip replacement.46-48 Except for a higher 
risk of infections among patients who had total hip 
replacement, evidence on all other outcomes was 
inconclusive.
Total knee replacement for end stage osteoarthritis
Of 344 retrieved articles, no reviews of randomised 
controlled trials comparing total knee replacement 
versus no treatment, placebo, or sham surgery for the 
treatment of end stage osteoarthritis were identified 
(fig 2; appendix 5). We found one randomised 
controlled trial published in 2015, which compared 
total knee replacement followed by non-surgical 
treatment versus non-surgical treatment alone 
(exercise, education, dietary advice, use of insoles, and 
analgesics) in patients with moderate to severe knee 
osteoarthritis who were eligible for unilateral total 
knee replacement.49 Findings showed that treatment 
with total knee replacement followed by non-surgical 
treatment resulted in greater pain relief and functional 
improvement after 12 months compared with 
non-surgical treatment alone; however, total knee 
replacement was associated with a high number of 
serious adverse events (appendix 8; fig 3).
Discussion
Using an umbrella review of systematic reviews and 
meta-analyses of randomised controlled trials, we 
sought to examine the body of evidence on the clinical 
effectiveness of 10 of the most elective common 
orthopaedic procedures and assess their impact on 
guideline recommendations. Of the 10 procedures, 
no randomised controlled trials have compared total 
hip replacement and meniscal repair for acute tears 
with non-operative care. The other eight procedures 
have been studied in such trials, and some evidence 
supports the superiority of total knee replacement and 
strongly supports carpal tunnel decompression over 
non-operative care. Randomised controlled trials have 
shown that arthroscopic anterior cruciate ligament 
reconstruction, arthroscopic partial meniscectomy, 
arthroscopic repair for acute rotator cuff tears, 
arthroscopic subacromial decompression, lumbar 
spinal decompression for spinal canal stenosis, and 
spinal fusion for degenerative disc disease have similar 
outcomes to non-operative care.
Comparison of our findings with the current 
recommendations and guidelines of national bodies 
is interesting (appendix 11). The American Academy 
of Orthopaedic Surgeons (AAOS) recommends using 
arthroscopic anterior cruciate ligament reconstruction 
in certain subgroups of patients,50 as well as using 
either rotator cuff repair or non-operative care for 
rotator cuff tears.51 The 2018 arthroscopic meniscal 
surgery treatment guidance from the British Association 
for Surgery of the Knee (BASK) recommends using 
arthroscopic meniscal repair to treat meniscal lesions 
of the knee in some patients,52 while acknowledging 
that no high quality level 1 evidence is available to 
support this. The NICE guideline recommendation is to 
use lumbar spine decompression when non-operative 
treatment has failed.53 NICE and other guideline 
bodies, on the basis of observational data, recommend 
total hip replacement for end stage osteoarthritis of the 
hip.54-56
Encouragingly, many of the guidelines from 
prominent national bodies closely reflect the current 
body of evidence. Consensus statements from 
guideline societies do not recommend arthroscopic 
partial meniscectomy in patients with knee pain and a 
meniscal tear,57 58 strongly recommend against the use 
of subacromial decompression surgery for subacromial 
impingement syndrome (appendix 10),35 59-61 support 
using open or endoscopic decompression for carpal 
tunnel syndrome,62 63 recommend against lumbar 
spine decompression for people with low back pain,53 
and recommend total knee replacement for end stage 
osteoarthritis of the knee. The evidence base for 
recommendations on total knee replacement was built 
wholly on observational retrospective studies that 
have often used prosthesis survival as the primary 
outcome measure.64 65 However, this guidance is now 
supported by the subsequent randomised controlled 
trial published in 2015.49
Although seven of the procedures (namely, 
arthroscopic anterior cruciate ligament reconstruction 
for anterior cruciate ligament rupture, arthroscopic 
meniscal repair of the knee for traumatic tears, 
arthroscopic rotator cuff repair for acute rotator cuff 
tears, carpal tunnel decompression for carpal tunnel 
syndrome, lumbar spine decompression for spinal 
canal stenosis, and total hip replacement and total knee 
replacement for end stage osteoarthritis) have been 
recommended for use by national guidelines, a high 
quality body of evidence on the clinical effectiveness 
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to definitively support these recommendations does 
not exist for most of these procedures. This is mainly 
a consequence of the lack of randomised controlled 
trials that compare the procedure with non-operative 
care. The evidence base for the recommendations 
was mostly built on comparisons involving two or 
more different techniques of the same procedure (for 
example, endoscopic versus open), observational 
retrospective studies and case series with no control 
groups, and expert opinions. For example, the 
recommendations for arthroscopic meniscal repair 
were based on mostly indirect evidence and low 
quality observational studies,52 and the guideline 
group highlighted this as a priority area for further 
research.52 For total hip replacement, the evidence 
for the recommendations was based on head-to-head 
comparisons between different types of hip prosthesis 
and uncontrolled studies that have used prosthesis 
survival as the primary outcome measure.56 This 
lack of randomised controlled trials evidence does 
not mean that the interventions are ineffective, but 
without evidence from randomised controlled trials, 
disentangling regression to the mean, surgical placebo, 
and the true treatment effect is extremely difficult.
Strengths and limitations of study
The strengths of this study include its novelty and the 
comprehensive search of well known databases as 
well as guidelines. Although umbrella reviews provide 
top level evidence and important insights on the 
clinical effectiveness of interventions, several inherent 
limitations to our review deserve consideration. 
Because of the absence of meta-analyses on a few 
procedures, due to the lack of randomised controlled 
trials, we used relevant study designs according 
to the hierarchy of evidence. We used the UK NICE 
guidelines evidence search for recommendations on 
each procedure, given that the study setting was the 
UK. The recommendations can be applied to other 
healthcare settings, however, as our search yielded 
guidelines from elsewhere in Europe and the US. 
Several meta-analyses did not use GRADE scores to 
appraise the quality of findings. Finally, several of the 
meta-analyses included in our review scored low when 
appraised with the AMSTAR tool, showing the need for 
future reviews to use accepted methods of reporting.
Explanations for findings
Surgery is expensive and associated with considerable 
morbidity, increased risk of complications attributed 
to the surgical intervention, and excess mortality. 
Seeking high level evidence to support surgery is thus 
imperative. When high level evidence shows that non-
operative care is equivalent, surgeons and patients 
should carefully consider what would be achieved 
by doing surgery. A cogent argument can be made 
for surgery being used as a second line treatment 
when non-surgical measures have failed or in certain 
subgroups of patients who have been identified as 
“responders” to surgical treatment. However, trials 
first need to be done to show the efficacy of surgery in 
these scenarios and to define the period of treatment 
with non-surgical interventions that is appropriate 
before surgery is undertaken. For an operation such as 
total hip replacement, the understandable assumption 
is made that all improvement is due to the surgery, 
but some may be due to the natural history including 
regression to the mean or treatment effect from non-
replacement co-interventions. Given the current 
waiting lists for surgery due to the covid-19 pandemic, 
a randomised controlled trial comparing total hip 
replacement with best non-surgical care may be 
timely, especially if those patients randomised to non-
operative care are subsequently offered surgery should 
they be dissatisfied with the outcome of non-operative 
care.
Some of these interventions are just not clinically 
effective or may be effective only when used in specific 
circumstances. For example, although the use of 
arthroscopic partial meniscectomy in patients with 
knee pain and a meniscal tear is not recommended, 
especially in patients with significant or end stage 
osteoarthritis, guidelines suggest that the procedure 
can be used for a specific type of meniscal tear and 
should be used only in patients who have not responded 
to a period of non-surgical treatment. Despite the 
good body of evidence on the clinical ineffectiveness 
of arthroscopic subacromial decompression, national 
clinical guidelines recommend its use for patients 
with pure subacromial shoulder impingement whose 
symptoms fail to resolve with adequate non-operative 
treatment.61
The observation that most commonly used and 
recommended orthopaedic procedures had a limited and 
low quality evidence base relating to their effectiveness 
is concerning. Why clinicians and healthcare systems 
would choose to offer these procedures with limited 
evidence of their clinical effectiveness may not be 
entirely clear but is partly justifiable. Important 
reasons include the lack of randomised controlled 
trials that compare the procedure with no treatment or 
placebo. Properly conducted definitive trials are more 
difficult to run with orthopaedic interventions than 
with drugs and other interventions.8 They are labour 
intensive and expensive, and they have a late response 
given the demand for long term follow-up and the 
potential for crossover between arms; hence, most 
studies are based on small case series. Problems with 
recruitment, blinding, and quality of reporting also 
contribute to the low quality standards of some of the 
orthopaedic trials contributing to this review. However, 
the large number of recent high quality orthopaedic 
randomised controlled trials being conducted in the 
UK is extremely encouraging,66-68 and the orthopaedic 
community should thus be lauded for its efforts. 
Another important reason for the lack of evidence is the 
failure of investigators to report their negative findings, 
the refusal of journals to publish such findings, or 
both. Although no-treatment or placebo controlled 
trials are feasible for some orthopaedic interventions, 
they may not be feasible for all. Some of the guideline 
bodies highlighted the need to prioritise research so 
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that some of these procedures, such as arthroscopic 
meniscal repair of the knee for traumatic tears, would 
be informed by a good evidence base. Furthermore, 
interventions may work, even if the evidence base has 
not yet been established, or the observational evidence 
may be so overwhelming that randomised controlled 
trials would be deemed unethical or redundant. Hip 
replacement may be an example of this.
Implications of findings
With these findings, a need exists for an improved 
and more rigorous approach to the recommendation 
of procedures with limited evidence on their clinical 
effectiveness. Over the past few years, NHS England, 
in partnership with NHS Clinical Commissioners, the 
Academy of Royal Medical Colleges, and NICE, has put 
forward proposals to stop or reduce the commissioning 
of various interventions that have inconclusive 
evidence for their clinical effectiveness; the goal of this 
is to improve safety for patients and curb unnecessary 
use of time and resources.61 69 70 On the basis of clinical 
evidence from various guidelines, including from 
NICE, 17 interventions have been selected and have 
been categorised as those that should not be routinely 
commissioned or performed and those that should 
be routinely commissioned or performed only when 
specific criteria are met.70 Featuring in the list were 
several orthopaedic procedures including arthroscopic 
subacromial decompression and carpal tunnel 
decompression. Of the 10 procedures that we studied, 
carpal tunnel decompression had the strongest 
evidence base supporting it. An urgent need exists 
to prioritise research, especially for the procedures 
with a limited evidence base, and for definitive 
randomised controlled trial designs to evaluate their 
clinical effectiveness. This will improve patient care, 
cut healthcare costs, permit more efficient use of our 
resources, and increase societal trust in orthopaedic 
interventions. A recent comment in The BMJ suggested 
that we should use “impactful, evidence based surgery 
alongside impactful, evidence based non-surgical care 
that may be faster, safer, and delivered at a lower cost.” 
Furthermore, with 10 million patients in England 
awaiting surgery, “now is an ideal time to invest in 
large platform trials.”7 The findings of this study 
support this view.
Conclusions
This umbrella review of the body of evidence on the 
10 most common elective orthopaedic procedures 
suggests that most of these procedures recommended 
by national guidelines and used by surgeons have 
insufficient readily available, high quality evidence on 
their clinical effectiveness, which is mainly because 
of a lack of definitive trials. This forces patients 
and clinicians to make decisions based solely on 
observational evidence. When randomised controlled 
trials have been conducted, they sometimes support 
observational evidence and expert opinion, but not 
universally so. To optimise decision making, surgeons 
should apprise themselves of the evidence, make 
decisions based on the highest quality trials available, 
and, in the absence of these, base their judgment on 
observational evidence, acknowledging that this may 
be imperfect. Simultaneously, surgeons and research 
funding bodies should actively contribute to filling 
the key knowledge gaps by enabling and participating 
in well constructed pragmatic randomised controlled 
trials.
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